Laurion Capital Management is a private hedge fund sponsor
Business Model:
Revenue: $0
Employees: 0-0
Address: 360 Madison Ave Rm 1900
City: New York
State: NY
Zip: 10017
Country: US
Laurion Capital Management is an investment advisory firm that provides hedge fund management strategies and financial services to investors.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2021 | Exscientia | Series D | 225M |
4/2023 | Axoni | Venture Round | 0 |
9/2020 | Recursion Pharmaceuticals | Series D | 239M |
11/2021 | Racket.com | Pre-Seed | 3M |
8/2022 | MerQube | Venture Round | 0 |
9/2022 | RayzeBio | Series D | 160M |
12/2021 | AnHeart Therapeutics | Series B | 0 |
3/2021 | Pyxis Oncology | Series B | 152M |
2/2022 | Scipher Medicine | Series D | 0 |
5/2019 | Schrödinger | Series E | 25M |
9/2021 | LEXEO Therapeutics | Series B | 0 |
12/2022 | Opensee | Series A | 11.7M |
8/2021 | Pepgen | Venture Round | 0 |
12/2021 | Ambys Medicines | Series A | 47M |
10/2022 | Recursion Pharmaceuticals | Post-IPO Equity | 150M |
2/2022 | Synthego | Series E | 0 |
3/2022 | TRex Bio | Series A | 0 |
4/2019 | SpringWorks Therapeutics | Series B | 125M |
9/2022 | Solid Biosciences | Post-IPO Equity | 75M |
8/2022 | MerQube | Venture Round | 0 |
3/2022 | TRex Bio | Series A | 0 |
2/2022 | Scipher Medicine | Series D | 0 |
2/2022 | Synthego | Series E | 0 |
12/2021 | Ambys Medicines | Series A | 0 |
12/2021 | AnHeart Therapeutics | Series B | 0 |
11/2021 | Racket.com | Seed Round | 0 |
9/2021 | LEXEO Therapeutics | Series B | 0 |
8/2021 | Pepgen | Venture Round | 0 |
4/2021 | Exscientia | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|